Standout Papers

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM rand... 2024 202693
  1. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials (2024)
    Mikhail Kosiborod, John Deanfield et al. The Lancet
  2. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial (2024)
    John Deanfield, Subodh Verma et al. The Lancet

Immediate Impact

2 from Science/Nature 68 standout
Sub-graph 1 of 22

Citing Papers

Protein codes promote selective subcellular compartmentalization
2025 StandoutScience
GLP-1-based therapies for diabetes, obesity and beyond
2025 Standout
1 intermediate paper

Works of Peter Weeke being referenced

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
2024 Standout
Whole Exome Sequencing Identifies a Causal RBM20 Mutation in a Large Pedigree With Familial Dilated Cardiomyopathy
2013

Author Peers

Author Last Decade Papers Cites
Peter Weeke 335 205 131 23 625
Francisca Rodríguez 165 250 147 31 721
Bénédicte Bénéteau‐Burnat 150 150 89 27 535
M. Hermle 242 227 103 23 740
S. Willoughby 230 93 183 23 592
Cumhur Bilgi 144 94 108 32 576
Yisong Zhen 207 272 100 27 620
Gabriella Passacquale 281 149 53 22 721
Mary Mamakeesick 193 125 225 23 683
Daniel Bulut 204 223 88 27 670
J. K. McKenzie 193 173 147 23 581

All Works

Loading papers...

Rankless by CCL
2026